Nitric oxide vs insulin secretion, action and clearance

Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study

(2013) Andrzej Surdacki et al.   Cardiovascular Diabetology

What do we learn from measurements of HOMA-IR?

(2013) G. M. Reaven   DIABETOLOGIA

Systemic inhibition of nitric oxide synthesis in non-diabetic individuals produces a significant deterioration in glucose tolerance by increasing insulin clearance and inhibiting insulin secretion

(2013) A. Natali et al.   DIABETOLOGIA

Insulin counteracts glucotoxic effects by suppressing thioredoxin-interacting protein production in INS-1E beta cells and in Psammomys obesus pancreatic islets

(2009) M. Shaked et al.   DIABETOLOGIA

Thioredoxin-interacting Protein (Txnip) Is a Feedback Regulator ofS-Nitrosylation

(2009) Michael T. Forrester et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation

(2008) Crystal M. Cordes et al.   BIOCHEMICAL PHARMACOLOGY